MoneyWorks4Me

Glenmark Pharmaceuticals informs about media release

16 Feb 2021 Evaluate

Glenmark Pharmaceuticals has informed that it has attached media release on 16th February 2021 titled ‘Glenmark launches SUTIB (Sunitinib)-priced 96% lower than the innovator brand. Reduces the risk of kidney cancer progression by 58%’ which is self?explanatory.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1777.60
Dr. Reddys Labs. 1190.10
Cipla 1316.50
Lupin 2001.20
Zydus Lifesciences 1122.00
View more..